#United States #Charlotte #Board of Directors #ISPE #Pharmaceutical Engineering

ISPE Unveils New Leadership for 2025-2026

The International Society for Pharmaceutical Engineering (ISPE) has officially announced the results of its elections for the 2025-2026 International Board of Directors. These newly elected leaders will play crucial roles in shaping the future of the organization, overseeing its governance and strategic initiatives within the pharmaceutical industry.

The election results were shared on September 3, 2025, revealing a diverse group of accomplished professionals who will guide the ISPE as it continues to address complex challenges faced by the pharmaceutical sector. The new Board members will take their positions at the upcoming ISPE Annual Meeting and Expo scheduled for October 26-29 in Charlotte, North Carolina, and online.

Leadership Roles in the New Board

Executive Committee

• - Chair: Vivianne Arencibia, the Vice President of Global Quality Systems and Compliance at Moderna, brings a wealth of experience in ensuring quality standards in pharmaceutical engineering.
• - Vice Chair: Ylva Ek, founder of Robur Life Science Advisory AB, offers deep insights into strategic advisory in life sciences.
• - Treasurer: David Churchward, Head of Operations Quality Compliance and External Affairs at AstraZeneca, will oversee the financial stewardship of the organization.
• - Secretary: Georg Singewald, PhD, serving as the Global Head of Quality and Compliance at Roche/Genentech, is responsible for maintaining records and facilitating effective communication.
• - Past Chair: Jeffrey Biskup, PE, holds the position of Executive Chairman of the Board at CRB, providing wisdom and guidance from previous leadership experience.
• - Ex Officio Non-Voting Member: Mike Martin, the President and CEO of ISPE, will provide ongoing insights and strategic direction.

Returning Board Member

• - Liz Dooley has been re-elected for a second term as Senior Director of Global Engineering and Technology at Johnson & Johnson, continuing her service on the Board.

New Additions to the Board

• - Jose Caraballo, Vice President of Quality Systems, Compliance, and Quality Engineering at Kite, a Gilead Company, joins the team to enhance quality oversight.
• - Victor Cruz, Senior Vice President of Corporate Engineering and Global Health, Safety, and Environmental at Eli Lilly & Company, brings expertise in corporate engineering initiatives.
• - Francesco Intoccia, Senior Vice President of Global Engineering Innovation at CSL Behring, will leverage his background in engineering innovation to propel ISPE’s mission forward.

Continuing Board Members

Several board members elected in 2023 will continue to serve during this new term:

• - Norman Goldschmidt, President of Genesis AEC
• - James Grunwald, Senior Vice President of US Business Development at Arcadis
• - Shanshan Liu, Technical Director at No Deviation Pte Ltd
• - Vivien Santillan, Regional Director, Asia at Novatek International

Departing Board Members

As the new members step into their roles, some board members are completing their service:

• - Scott Billman, Senior Vice President of Global Engineering, Technology, and Facilities at Solventum, will conclude his term.
• - Sarah Pope Miksinski, PhD, Executive Director of CMC Regulatory Affairs at Gilead Sciences, and Timothy Watson, PhD, Vice President and Head of CMC Regulatory Affairs at Gilead Sciences also complete their service.

A Transparent Election Process

The election was conducted by an independent third-party organization, ensuring an unbiased and credible outcome for the ISPE membership. This commitment to transparency and integrity in the electoral process reaffirms ISPE's dedication to good governance.

About ISPE

Founded in 1980, ISPE is a global nonprofit association with a mission to advance the pharmaceutical industry through scientific, technical, and regulatory leadership. With a membership surpassing 23,000 professionals in over 120 countries, ISPE provides solutions to complex challenges in pharmaceutical engineering and fosters innovation and collaboration within the industry. For more information, please visit ISPE.org.

As the new Board members step into their roles, they carry the aspirations of ISPE's mission forward, propelling the pharmaceutical industry towards a more advanced and compliant future.